 | Up a level |
Colombo, S; Buclin, T; Décosterd, LA; Telenti, A; Furrer, H; Lee, BL; Biollaz, J; Eap, CB; Swiss, HIV Cohort Study (2006). Orosomucoid (alpha1-acid glycoprotein) plasma concentration and genetic variants: effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation. Clinical pharmacology & therapeutics, 80(4), pp. 307-18. New York, N.Y.: Nature Publishing Group 10.1016/j.clpt.2006.06.006
Colombo, S; Telenti, A; Buclin, T; Furrer, H; Lee, BL; Biollaz, J; Decosterd, LA; Swiss, HIV Cohort Study (2006). Are plasma levels valid surrogates for cellular concentrations of antiretroviral drugs in HIV-infected patients? Therapeutic drug monitoring, 28(3), pp. 332-8. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/01.ftd.0000211807.74192.62
Rotger, M; Colombo, S; Furrer, H; Bleiber, G; Buclin, T; Lee, BL; Keiser, O; Biollaz, J; Décosterd, L; Telenti, A; Swiss, HIV Cohort Study (2005). Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients. Pharmacogenetics and genomics, 15(1), pp. 1-5. London: Lippincott Williams & Wilkins
Martin, JN; Perdreau-Remington, F; Kartalija, M; Pasi, OG; Webb, M; Gerberding, JL; Chambers, HF; Täuber, MG; Lee, BL (1999). A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. Journal of infectious diseases, 180(3), pp. 896-9. Cary, N.C.: Oxford University Press 10.1086/314949
Gilbert, DN; Lee, BL; Dworkin, RJ; Leggett, JL; Chambers, HF; Modin, G; Täuber, MG; Sande, MA (1998). A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate. American journal of medicine, 105(3), pp. 182-91. Orlando, Fla.: Elsevier 10.1016/S0002-9343(98)00244-7
Lee, BL; Täuber, MG; Sadler, B; Goldstein, D; Chambers, HF (1996). Atovaquone inhibits the glucuronidation and increases the plasma concentrations of zidovudine. Clinical pharmacology & therapeutics, 59(1), pp. 14-21. New York, N.Y.: Nature Publishing Group 10.1016/S0009-9236(96)90019-3
Lee, BL; Padula, AM; Täuber, MG; Chambers, HF; Sande, MA (1992). Oral SCH 39304 as primary, salvage, and maintenance therapy for cryptococcal meningitis in AIDS. Journal of acquired immune deficiency syndromes JAIDS, 5(6), pp. 600-4. Philadelphia, Pa.: Lippincott Williams & Wilkins
